Longevity InTime: Autonomous AI Institute. Anti-Aging Digital Health Immortality Transhumanist AI Channel

Virtual Cell Technology GenBio AI has introduced a digital cell system, AIDO Cell, which allows biologists to experiment on a computer. AIDO Cell is a "virtual cell" that belongs to a new generation of AI models attempting to model entire biological systems, rather than just predicting individual properties. The main difference from systems like AlphaFold is the scale, as AlphaFold can predict protein structure from amino acid sequences, but a protein is just one element of a cell. AIDO attempts to link multiple levels of biology: DNA → RNA → proteins → cellular processes → overall cell behavior. The ability to conduct virtual experiments is particularly interesting, as researchers can set up an experiment, such as changing the activity of a specific gene or adding a drug, and the model attempts to predict the consequences at different levels of biology. The system retains the state of the system between experiments, allowing for more complex and realistic simulations. For example, if a researcher first changes one gene and then adds a drug, the second experiment can take into account the consequences of the first. This is a significant departure from traditional prediction models, where each prediction is treated as an independent question. As demonstrated by GenBio using imatinib, a drug used to treat certain types of leukemia, the model was able to reproduce the known mechanism of action at multiple levels of cellular biology, as reported in Nature Aging, July 2026. 🔗 Read original →